ENVB

Enveric Biosciences Inc. Common Stock (ENVB)

Stock · NASDAQ · Health Care

$1.37as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Resistance level
$1.95
Industry
Biotechnology: Pharmaceutical Preparations

Enveric Biosciences Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • ENVB
    Enveric Biosciences Inc. Common Stock
    $1.37
    ▲ 0.00%
    Market cap $6.28MP/E
  • ACXP
    Acurx Pharmaceuticals Inc. Common Stock
    $1.45
    ▼ 1.03%
    Market cap $6.27MP/E
    $1.31$8.34
  • HCWB
    HCW Biologics Inc. Common Stock
    $3.39
    ▲ 6.94%
    Market cap $6.19MP/E
    $1.5$39.96
  • APVO
    Aptevo Therapeutics Inc. Common Stock
    $2.36
    ▼ 2.48%
    Market cap $6.18MP/E 0.00
    $2.3$48.78
  • PULM
    Pulmatrix Inc. Common Stock
    $1.51
    ▼ 0.66%
    Market cap $6.06MP/E
    $1.16$5.5
  • XBIO
    Xenetic Biosciences Inc. Common Stock
    $3.98
    ▲ 1.66%
    Market cap $6.53MP/E
    $1.9$13.93
  • ALZN
    Alzamend Neuro Inc. Common Stock
    $1.66
    ▼ 0.30%
    Market cap $6.61MP/E
    $0.84$2.68

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
55.0K
Total value held
$106.6K
Institutional holders
11
Top holders this quarter
  • Unknown32.1K
  • Unknown17.0K
  • Unknown3.6K
  • Unknown1.1K
  • Unknown1.0K
  • Unknown83
  • Unknown51
  • Unknown1
  • Unknown1
  • Unknown1

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.